Lipocine Inc(NASDAQ:LPCN) 
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.95
H 3.32
L 2.95
C 3.01
V 8,217
10EMA 3.01
20EMA 3.01
60EMA 3.01
120EMA 3.01
250EMA 3.01